Effects of combination therapy of fluvastatin/fenofibrate versus simvastatin/ezetimibe on LDL-subfractions in patients with the metabolic syndrome

Authors
Category Primary study
JournalAtherosclerosis Supplements
Year 2009
This article has no abstract
Epistemonikos ID: 9b6ad7e855aa4658db0af2fdd0822687762ab7a9
First added on: Feb 28, 2025